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Summary Dengue fever (DF)/dengue hemorrhagic fever (DHF) has emerged as a
global public health problem with countries in Asia and the Paciﬁc sharing more than
70% of the disease burden. In 2004—2005 a total of 312 cases admitted to Pediatric
and Sea Port Hospitals in Port Sudan were clinically diagnosed as DHF. The mortality
rate recorded was 3.8% (n = 12). Of the cases 73.4% were patients 5—15 years of
age. A total of 91.2% of cases were admitted during May and June 2005 with 49.4%
residing in the eastern region of Port Sudan. Dengue shock syndrome was observed
in 37 of 312 (11.9%). All patients had thrombocytopenia with platelets count ranged
from <100,000 to <150,000 cell/mm3. Of the 40 sera tested using RAPID-cassette
test in the Khartoum Central Public Health Lab, 36 (90%) were dengue IgM positive.
A subset of these sera (n = 23) were sent to NAMRU-3 and conﬁrmed by IgM-capture
ELISA; 9 of 23 were PCR positive for dengue serotype 3.
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ntroductionengue fever (DF) is the most important disease
aused by the dengue (DEN) virus of family Fla-
iviridae and transmitted by the Aedes aegypti
osquito. Dengue virus exists as four distinct
∗ Corresponding author. Tel.: +20 127876102;
ax: +20 223427121.
E-mail address: atef.soliman.eg@med.navy.mil (A. Soliman).
d
i
i
l
t
g
t
876-0341/$ — see front matter. Published by Elsevier Limited on behalf of Kin
oi:10.1016/j.jiph.2010.08.001reserved.
erotypes, DEN-1—4. DF, dengue hemorrhagic fever
DHF) and dengue shock syndrome (DSS) have
merged as a global public health problem in recent
ecades. DHF and DSS are most commonly observed
n children under 15 years, but they also occur
n adults [1]. Infection with one serotype gives
ife-long immunity for that serotype but not to
he others. Secondary infection with a heterolo-
us serotype from the primary infection enhances
he risk of developing DHF/DSS [2]. Dengue is
g Saud Bin Abdulaziz University for Health Sciences. All rights reserved.
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Figure 1 Distribution of DHF cases during November
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known to occur in Sudan, however, reporting is
subject to limited diagnostic capacity. DEN-2 was
ﬁrst reported in Port Sudan in 1986 [3]. An out-
break of acute febrile illness occurred later in
1989 in the Northern Province of Sudan and the
prevalence of DEN-2 antibody was 24% [4]. Addi-
tional serological evidence of DEN-2 infection in
Sudan was reported 1995 [5]. The aim of this
study was to describe the etiology and clinical
ﬁndings of dengue cases admitted to main hospi-
tals in Port Sudan from November 2004 to June
2005.
Materials and methods
Clinical and demographic data were collected from
each child admitted to the Pediatric Emergency
and Red Sea Port hospitals in Port Sudan with
suspected dengue infection during (as per WHO
case deﬁnition) November 2004 to September 2005.
Blood samples were collected for platelet count.
Serum samples were tested at the Central Public
Health Laboratory (CPHL) in Khartoum for DEN-IgM
antibodies using RAPID-Cassette test (PanBio, Bris-
bane QLD, Australia) kits. Frozen aliquots of sera
were sent to NAMRU-3 for conﬁrmation using DEN-
IgM-capture-ELISA (PanBio). RNA extractions were
conducted on sera using Qiagen Viral RNA Mini Kits,
nested PCR ampliﬁcation of the C gene (∼0.3 kb) [6]
and direct sequencing of PCR products using the ABI
3100 genetic analyzer (Applied Biosystems, Foster
City, CA., USA).
Results
A total of 312 patients with clinically suspected
DHF were admitted to the pediatric and Red Sea
Port hospitals during the study period. The major-
ity of the patients (n = 229, 73.4%) were between
5 to 15 years of age, while the remaining (n = 83,
26.6%) were below 5 years of age, 59.6% of the
patients were males. Patients were predominantly
(91.2%) admitted to the hospitals during the months
of May and June 2005 (Fig. 1), 49.4% of them were
from Eastern region (close to the Red Sea port) and
32.4% (101/312) were from local tribes living in Port
Sudan. The clinical manifestations of the DHF cases
are summarized in Table 1. Fourteen cases devel-
oped convulsions and 4 had cerebral hemorrhage.
The mortality rate recorded was 3.8% (n = 12), of
which 11 (91.7%) had typical DSS. Eight of 12 mor-
talities (66.7%) recorded were among the 10—15
years age group. Patients with DSS received oxygen,004—September 2005.
ntravenous ﬂuids, plasma, platelets, fresh blood
nd supportive medicine each case as required.
esponse of these patients to treatment was ade-
uate in some despite of high mortality in this
roup of patients. A total 37 of 312 (11.9%) hemor-
hagic cases developed DSS. Thrombocytopenia of
100,000 cell/mm3 was recorded in 75.6% of cases
hile 25.4% had mild thrombocytopenia (100,000 to
150,000), 49 cases received fresh blood transfu-
ion, 22 received plasma and platelets and 13 cases
eceived both fresh blood and platelets. Only 40
erum samples were tested in CPHL in Khartoum
ue to lack of testing facilities and transportations
rom Port Sudan to Khartoum, of these samples
0% were dengue IgM positive by RAPID-cassette
est. Of 40 serum samples 23 had enough volume
or further conﬁrmation at NAMRU-3 and all were
onﬁrmed by IgM-capture ELISA kits. Nine of 23
ere PCR positive for DEN virus serotype 3 (DEN-3).
last search of the PCR product sequences showed
99% identity (288 bp fragment) to DEN-3 isolated
uring dengue outbreak in India in 2003 and to
EN-3 detected during the outbreak in Yemen in
004/2005 (Figs. 2—6).Figure 2 Sub conjunctival hemorrhage.
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n outbreak of a febrile disease consistent with
HF was identiﬁed in May and June of 2005 in Port
udan. Testing of a subset of patients conﬁrmed this
utbreak to be dengue fever. Onset in May coin-
ided with a brief rainy season [7]. No further cases
ere noted in July, however, much of the popula-
w
[
d
o
Figure 4 Plethoric hands, legs andg, epistaxis and cracked lips.
ion of Port Sudan leave the city during July and
ugust to escape the extreme heat.
All patients admitted had clinical picture consis-
ent with DHF. Clinical manifestations and mortality
ere consistent with previously published ﬁndings
8]. Convulsions reported in some patients could be
ue to fever or other diseases, the cerebral hem-
rrhage was diagnosed clinically for no access to
feet at the end of the disease.
4 A. Malik et al.
th e
o
c
r
w
p
c
wFigure 5 DHF wi
neuroimaging but cases were associated with low
platelets count (<14000). It is worth mentioning
that, cases with hematemesis or melena associated
with fever had no previous history of GIT problems,
cases were diagnosed clinically with no need for
endoscopy. Schistosomiasis that may cause portal
hypertension is not circulating in the region and
the relatively high rate of hematemesis or melena
could be due to new serotype of DHF virus or the
extensive use of steroids to control fever before
admission to the hospital. In general, patients with
mild disease either do not present to the hospital,
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Figure 6 Fatal melena acchymosis cases.
r aremanaged as outpatients. There is very limited
apacity for both inpatient care (no ICU) and labo-
atory diagnosis in Port Sudan. All patients admitted
ere age 15 or less. This reﬂects the age of the
opulation served by the hospitals and pediatrician
onducting the evaluations. No clinical information
as available on disease among adults.
The dengue serotype causing this outbreak wasEN-3. Although dengue fever is known to occur
n Port Sudan, DEN-3 had not previously been
etected. Introduction of DEN-3 helps explain the
igh number of cases of DHF. In November of 2004,
nd mouth bleeding.
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Table 1 Demographic and clinical data of DHF
patients.
Demographic and clinical data DHF patients
n = 312
N (%)
Age in years
<1 9 (2.9)
1 to <5 74 (23.7)
5 to <10 117 (37.5)
10—15 112 (35.9)
Male gender 186 (59.6)
Race/ethnicity/tribe
Hadandaw 53 (17.0)
Rashiada 1 (0.3)
Bani Amer 45 (14.4)
Aritrian 2 (0.6)
Others 211 (67.6)
Residence in Port Sudan
Eastern 154 (49.4)
Northern 39 (12.5)
Southern 60 (19.2)
Central 49 (15.7)
Sawakin 5 (1.6)
Missing 5 (1.6)
Bleeding manifestations
Hematemesis 115 (36.9)
At venipuncture 111 (35.6)
Epistaxis 108 (34.6)
Melena 102 (32.7)
Pupura 14 (4.5)
Gum bleeding 14 (4.5)
Other sites 11 (3.5)
Clinical manifestations
Fever 312 (100.0)
Abdominal pain 163 (52.2)
Skin rash 84 (26.9)
Plethoraa 68 (21.8)
Hepatomegaly 28 (8.9)
Hemorrhagic manifestation in fatal cases (n = 12)
Melena 11 (91.7)
Shock 11 (91.7)
Hematamesis 8 (66.7)
Epistaxis 2 (16.7)
Age distribution in fatal cases (n = 12)
<5 years 1 (8.3)
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prepared as part of my ofﬁcial duties. Title 17>5 to <10 years 3 (25.0)
>10—15 years 8 (66.7)
a An excess of blood in one area of the body.
emen experienced onset of an outbreak of DEN-
that coincided with this outbreak (unpublished
ata). Over the past two decades, dengue virus
erotype 3 (DENV-3) has caused unexpected epi-
emics of DHF in Sri Lanka, East Africa, and Latin
merica. The emergence of DHF in Sri Lanka in
989 correlated with the appearance there of a
ew DENV-3, subtype III variant. This serotype likely
pread from the Indian subcontinent into Africa in
U
t
t
tSudan 5
he 1980s and from Africa into Latin America in the
id-1990s [9].
Following this outbreak in Port Sudan, cases of
HF were anecdotally reported from as far East as
assala and Central as Kordofan (Ministry of Health,
udan). Aedes mosquitoes have been reported from
any different regions of Sudan (personal com-
unications). Much of the population of Sudan is
t risk for dengue infection. Introduction of new
erotypes into the region increases the chances
f the population suffering from DHF. There is a
eed for enhanced the laboratory diagnostic capac-
ty and implementation of preventive measures like
ectors control and quarantine at the ports and
rograms to include different governmental sectors
n the country (Ministries of health, environment,
griculture, and interior) particularly in high risk
reas like Port Sudan.
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